Speranta IACOB medic specialist gastroenterolog, doctor in stiinte medicale Data si locul nasterii: 8 aprilie 1977, Bucuresti, Romania Telefon/Fax:
|
|
- Harriet Eunice Booth
- 6 years ago
- Views:
Transcription
1 Speranta IACOB medic specialist gastroenterolog, doctor in stiinte medicale Data si locul nasterii: 8 aprilie 1977, Bucuresti, Romania Telefon/Fax: msiacob@yahoo.com Etape medicale si universitare: : UMF Carol Davila, Bucuresti, Facultatea de Medicină Generală Medic rezident pediatrie, Clinica de Pediatrie, Institutul Clinic Fundeni, Bucuresti Medic rezident gastroenterologie, Centrul de Gastroenterologie si Hepatologie, Institutul Clinic Fundeni, Bucuresti Octombrie Promovarea examenului de medic specialist în gastroenterologie; încadrarea ca medic specialist la Centrul de Gastroenterologie si Hepatologie Fundeni 2007 prezent Medic specialist gastroenterologie, Centrul de Gastroenterologie si Hepatologie, Institutul Clinic Fundeni, Bucuresti Martie Promovarea examenului de asistent de cercetare în gastroenterologie : Asistent de cercetare, Centrul de Gastroenterologie si Hepatologie, Institutul Clinic Fundeni, Bucuresti Septembrie Promovarea examenului de cercetător stiintific în gastroenterologie : Cercetator stiintific, Centrul de Gastroenterologie si Hepatologie, Institutul Clinic Fundeni, Bucuresti Noiembrie 2010 Promovarea examenului pentru ocuparea postului de medic specialist gastroenterologie : Doctorand in specialitatea Chirugie Generala Transplant hepatic Conducator stiintific Prof. Dr. Irinel Popescu 12 Noiembrie 2010 Sustinerea tezei de doctorat cu titlul Hepatita cronica C recurenta posttransplant hepatic strategii terapeutice si factori asociati recurentei severe si obtinerea titlului de Doctor in stiinte medicale
2 7 Septembrie 2011 Promovarea examenului organizat de UEMS (European Union of Medical Specialists), EBTM (European Board of Transplantation Medicine) si ESOT (European Society of Organ Transplantation) si obtinerea Diplomei Europene in Medicina de Transplant ( European Diploma in Transplantation Medicine ) Pregatire postuniversitara in gastroenterologie si hepatologie Curs si stagiu practic de gastroenterologie si hepatologie Franta : EDOUARD HERRIOT hopital, Lyon (March April 2002) Curs si stagiu practic de gastroenterologie si hepatologie Olanda : Amsterdam (Academic Medical Center), Zwolle (The Sophia Ziekenhuis Zwolle) (Septembrie Octombrie 2003) 25 cursuri postuniversitare ( ) EASL School of Hepatology Curs 1 Bolile cronice hepatice, Geneva, Elvetia (Decembrie 2003) EASL School of Hepatology Curs 2 Complicatiile cirozei si cancerul hepatic, Barcelona, Spania (Iunie 2004) DAAD Scholarship SUPRASPECIALIZARE TRANSPLANT HEPATIC, Spitalul Universitar Essen, Germania (1 Iunie 30 Noiembrie 2005) Stagiu de cercetare fundamentala in Biologie Moleculara si Celulara, Spitalul Universitar Essen, Germania (1 Ianuarie 31 Decembrie 2009) Afiliere la societati: AN SOCIETATE 2001-prezent Membra a Societatii Romane de Gastroenterologie si Hepatologie (SRGH) 2001-prezent Membra a Societatii Romane de Endoscopie Digestiva (SRED) 2002-prezent Membra a Societatii Romane de Nutritie Enterala si Parenterala (ROSPEN) 2002-prezent Membra a ROMTRANSPLANT 2003-prezent Membra a International Association of Surgeons and Gastroenterologists (IASG) 2003-prezent Membra a American College of Gastroenterology (AGA) Feb prezent Membra a European Association for the Study of the Liver (EASL) Iunie 2008-prezent Membra a Transplantation Society (TTS) August 2008-prezent Membra a European Society for Organ Transplantation (ESOT) Septembrie 2008 Includere in WHO s WHO in lume in 2009 Iulie 2009 prezent Membra fondatoare a Women Leaders in Transplantation (WLIT) Premii si burse primite: - 19 burse ca tanar investigator pentru participare la diferite congrese internationale (incepand din ) - Bursa acordata de DAAD (Serviciul German de Schimb Academic) (2005) - Bursa de cercetare acordata pentru tinerii doctoranzi de catre CNCSIS (Mai 2007-Martie 2010) - Invitata de catre Societatea Internationala de Transplant la TTS New KOL Meeting as New Key Opinion Leader (nkol), Sankt Petersburg, Russia Real time elastography a noninvasive tool for evaluation of recurrent hepatitis C following liver transplantation premii (premiul I, II, III si mentiune) pentru prezentari orale sau postere (4
3 premii internationale si 11 premii nationale) Arii de interes in cercetare Transplantul hepatic Diagnosticul si tratamentul hepatitelor virale Ciroza hepatica si managementul complicatiilor Bolile colestatice ale adultului Boala Wilson hepatica Cancerul hepato-biliar diagnostic precoce si tratament Participare la granturi obtinute prin concurs: : 3 granturi nationale (unul de aproximativ 26000Eur, 2 de ~19000Eur) : 4 granturi nationale (fiecare de Eur) : 3 granturi nationale (fiecare de ~ Eur) Participare la 7 trialuri medicale internationale (co-investigator) Lucrari elaborate: Lucrari originale publicate in extenso 1. Diculescu M., Iacob S., Iacob R., Sclifos D., Ionescu R., Oproiu A. - Is oral bile acid dissolution a better alternative to laparoscopic cholecystectomy for patients with gallbladder stones? - Annals of Fundeni Hospital vol 6, nr. 1, january-march 2001, pp Diculescu M., Iacob R, Iacob S., Croitoru A., Becheanu G., Popeneciu V. - The Importance of Histopathological and Clinical Variables in Predicting the Evolution of Colon Cancer - Romanian Journal of Gastroenterology 2002 Sep;11(3): Gheorghe C., Gheorghe L., Iacob R., Iacob S., Simionov I., Bancila I. Argon Plasma Coagulation for Radiation Proctitis Romanian Journal of Gastroenterology 2003 June; 12(2): Vadan R., Gheorghe L., Becheanu G., Iacob R., Iacob S., Gheorghe C. Predictive factors for the severity of liver fibrosis in patients with chronic hepatitis C and moderate alcohol consumption - Romanian Journal of Gastroenterology 2003 Sep; 12(3): Gheorghe L, Iacob S, Bolog N, Stoicescu A, Parvulescu I, Popescu I. Overlap syndrome between autoimmune hepatitis and primary biliary cirrhosis complicated by hepatocellular carcinoma. Case report - Romanian Journal of Gastroenterology 2004 March; 13 (1): Gheorghe L, Iacob S, Gheorghe C, Iacob R, Simionov I, Vadan R, Becheanu G, Parvulescu I, Toader C. - Frequency and predictive factors for overlap syndrome between autoimmune hepatitis and primary cholestatic liver disease European Journal of Gastroenterology and Hepatology 2004; June, 16 (6): Gheorghe L., Popescu I., Iacob S., Gheorghe C., Vadan R., Constantinescu A., Iacob R., Becheanu G., Angelescu C, Diculescu M. - Wilson s disease: a challenge of diagnosis. The 5-years experience of a tertiary center - Romanian Journal of Gastroenterology 2004 September; 13 (3): C. Gheorghe, O. Pascu, L. Gheorghe, R. Iacob, E. Dumitru, M. Tantau, R. Vadan, A. Goldis, G. Balan, S. Iacob, D. Dobru, A. Saftoiu. Epidemiology of inflammatory bowel disease in adults who refer to gastroenterology care in Romania: a multicentric study - European Journal of Gastroenterology and Hepatology 2004; November, 16 (11): L. Gheorghe, S. Iacob, I. Popescu. Living donor liver transplantation and hepatitis C. Rom J Gastroenterol 2004 December; 13 (4):
4 10. Diculescu M, Iacob R, Chira C, Mihaila D, Iacob S. Esomeprazole in the treatment of patients with heartburn and other upper gastrointestinal symptoms, referred to primary care - results of the in-practice evaluation program in Romania. Rom J Gastroenterol Mar;14(1): Gheorghe L, Popescu I, Iacob R, Iacob S, Gheorghe C. Predictors of death on the waiting list for liver transplantation characterized by a long waiting time. Transpl Int May;18(5): Gheorghe L., Grigorescu M., Iacob S., Damian D., Gheorghe C., Iacob R., Simionov I., Vadan R., Parvulescu I., Bancila I. Effectiveness and tolerability of Pegylated interferon α-2a and ribavirin combination therapy in Romanian patients with chronic hepatitis C: from clinical trials to clinical practice - Rom J Gastroenterol Jun;14(2): Gheorghe L, Iacob R, Vadan R, Iacob S, Gheorghe C. Improvement of hepatic encephalopathy using a modified high-calorie high-protein diet. Rom J Gastroenterol Sep;14(3): Gheorghe L, Iacob S, Simionov I, Vadan R, Gheorghe C, Iacob R, Parvulescu I, Constantinescu I. Natural history of compensated viral B and D cirrhosis. Rom J Gastroenterol Dec;14(4): Iacob R, Iacob S, Gheorghe L, Gheorghe C, Diculescu M. The use of IT in the medical system has economic and research advantages - the experience of Fundeni Gastroenterology and Hepatology Center. Rom J Gastroenterol Dec;14(4): Cristian Gheorghe, Liana Gheorghe, Speranta Iacob, Razvan Iacob, Irinel Popescu. Primary prophylaxis of variceal bleeding in cirrhotics awaiting liver transplantation. Hepato-Gastroenterology 2006; 53: Popescu I, Tulbure D, Gheorghe L, Hrehoret D, Popa L, Iacob S, Malago M. Emergency protocol for an adult ABO-incompatible living related liver transplantation. Annals of Fundeni Hospital 2006;10: Gheorghe L, Iacob S, Sporea I, Grigorescu M, Sirli R, Damian D, Gheorghe C, Iacob R. Efficacy, tolerability and predictive factors for early and sustained virologic response in patients treated with weight-based dosing regimen of PegIFN α-2b and ribavirin in real-life healthcare setting. J Gastrointestin Liver Dis 2007; 16(1): Speranta Iacob, Vito R. Cicinnati, Philip Hilgard, Razvan A. Iacob, Liana S. Gheorghe, Irinel Popescu, Andrea Frilling, Massimo Malago, Guido Gerken, Christoph E. Broelsch, Susanne Beckebaum. Predictors of graft and patient survival in HCV recipients - model to predict HCV cirrhosis following liver transplantation. Transplantation 2007; 84:56-63 *Models for predicting graft and patient survival and hepatitis C virus recurrence after liver transplantation Predictors of graft and patient survival in hepatitis C virus (HCV) recipients: model to predict HCV cirrhosis after liver transplantation. Iacob S, Cicinnati VR, Hilgard P, Iacob RA, Gheorghe LS, Popescu I, et al. Transplantation 2007; 84:56-63 Comments by Perkins JD. In Liver Transplantation 2008;14: Cicinnati VR, Iacob S, Klein CG, Baba HA, Sotiropoulos GC, Hilgard P, Erim Y, Broelsch CE, Gerken G, Beckebaum S. Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantation. Aliment Pharmacol Ther 2007; 26:
5 21. L. Gheorghe, S. Iacob, R. Iacob, C. Gheorghe, I. Popescu. Variation of the MELD score as a predictor of death on the waiting list for liver transplantation. J Gastrointestin Liver Dis 2007; 16(3): *Lake JR. MELD-an imperfect, but thus far the best, solution to the problem of organ allocation. J Gastrointestin Liver Dis 2008; 17 (1): Gheorghe L, Iacob S, Gheorghe C, Herlea V, Becheanu G, Ardeleanu C, Dumbrava M, Lupescu I, Popescu I. Ecoendoscopic elastography for the diagnosis of hepatocellular carcinoma in small cirrhotic nodules. Archives of the Balkan Medical Union 2007; 42: Popescu I, Dima S, Guja C, Gheorghe L, Iacob S, Hrehoret D, Matei E, Dorobantu B, Botea F, Sarbu V, Tulbure D, Ionescu-Tirgoviste C. Combined liver and islet transplantation using steroid-free immunossupression. Chirurgia (Bucur) 2007;102: Gheorghe L, Iacob S, Lupescu I, Popescu H, Budai A. Percutaneous radiofrequency ablation for hepatocellular carcinoma. Archives of the Balkan Medical Union 2008; 43: Speranta Iacob, Liana Gheorghe, Doina Hrehoret, Gabriel Becheanu, Vlad Herlea, Irinel Popescu. Pegylated Interferon α-2a and Ribavirin Combination Therapy in HCV Liver Transplant Recipients. Experience of 7 Cases. J Gastrointestin Liver Dis 2008; 17: Gheorghe L, Iacob S, Csiki IE. Prevalence of hepatitis C in Romania: Different from European rates? J Hepatol 2008; 49(4): Gheorghe C, Iacob R, Gheorghe L, Cotruta B, Bancila I, Iacob S, Bucur D, Voinea D, Popescu I. Projected Dynamics of Colonoscopic Screening and Surveillance for Colorectal Cancer. Hepato-Gastroenterology 2008; 55: Gheorghe L, Iacob S, Gheorghe C. Real-time sonoelastography a new application in the field of liver disease. J Gastrointestin Liver Dis. 2008;17(4): Iacob S, Hrehoret D, Matei E, Dorobantu B, Gangone E, Gheorghe L, Popescu I. Costs and efficacy of "on demand" low-dose immunoprophylaxis in HBV transplanted patients: experience in the Romanian program of liver transplantation. J Gastrointestin Liver Dis. 2008;17(4): Gheorghe L, Iacob S, Grigorescu M, Sporea I, Sirli R, Damian D, Gheorghe C, Iacob R. High sustained virological response rate to combination therapy in genotype 1 patients with histologically mild hepatitis C. J Gastrointestin Liver Dis 2009;18: Iacob R, Sirbu-Boeti P, Iacob S, Dima S, Gheorghe C, Gheorghe L; Popescu I. Stem cell therapies for gastrointestinal and liver diseases. Chirurgia (Bucur) 2009;104: Iacob S, Gheorghe L, Iacob R, Gheorghe C, Hrehoret D, Popescu I. MELD exceptions and new predictive score of death on long waiting lists for liver transplantation. Chirurgia (Bucur) 2009;104: Popescu I, Habib N, Dima S, Hancu N, Gheorghe L, Iacob S, Mihaila M, Dorobantu B, Matei E, Botea F. Domino liver transplantation using a graft from a donor with familial hypercholesterolemia: seven-yr follow-up. Clinical Transplant 2009;23: Gheorghe L, Iacob S, Iacob R, Dumbrava M, Becheanu G, Herlea V, Gheorghe C, Lupescu I, Popescu I. Real Time Elastography a noninvasive diagnostic method of small hepatocellular carcinoma in cirrhosis. J Gastrointestin Liver Dis 2009;18 (4):
6 35. Dima S, Iacob S, Botea F, Matei E, Brasoveanu V, Hrehoret D, Vasile S, Alexandrescu S, Croitoru A, Dumitrascu T, Herlea V, Popescu I. Multimodal Treatment of Hepatocellular carcinoma: An Eastern European Experience. Hepato-Gastroenterology 2009; 56 (96): Iacob S, Cicinnati VR, Beckebaum S. Current immunosuppressive approaches in liver transplantation. Panminerva Med 2009;51: Beckebaum S, Iacob S, Klein CG, Dechêne A, Varghese J, Baba HA, Sotiropoulos GC, Paul A, Gerken G, Cicinnati VR. Assessment of Allograft Fibrosis by Transient Elastography and Noninvasive Biomarker Scoring Systems in Liver Transplant Patients. Transplantation. 2010;89: Popescu I, Ionescu M, Brasoveanu V, Hrehoret D, Matei E, Dorobantu B, Zamfir R, Alexandrescu S, Grigorie M, Tulbure D, Popa L, Ungureanu M, Tomescu D, Droc G, Popescu H, Cristea A, Gheorghe L, Iacob S, Gheorghe C, Boros M, Lupescu I, Vlad L, Herlea V, Croitoru M, Platon P, Alloub A. Liver transplantation - indications, surgical technique, results - the analysis of a clinical series of 200 cases. Chirurgia 2010;105: Gheorghe L, Pascu O, Ceausu E, Csiki IE, Iacob S, Caruntu F, Simionov I, Vadan R. Access to Peginterferon plus Ribavirin therapy for hepatitis C in Romania between J Gastrointestin Liver Dis 2010; 19: Shen Q, Cicinnati V, Zhang X, Iacob S, Weber F, Sotiropoulos G, Radtke A, Lu M, Paul A, Gerken G, Beckebaum S. Role of microrna-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion. Molecular Cancer 2010, 9: Sporea I, Sirli R, Curescu M, Gheorghe L, Popescu A, Bota S, Iacob S. Outcome of antiviral treatment in patients with chronic genotype 1 HCV hepatitis. A retrospective study in 507 patients. J Gastrointestin Liver Dis. 2010;19(3): Gheorghe L, Csiki IE, Iacob S, Gheorghe C, Smira G, Regep L. The prevalence and risk factors of hepatitis C virus infection in adult population in Romania: a nationwide survey J Gastrointestin Liver Dis. 2010;19(4): Beckebaum S, Iacob S, Sweid D, Sotiropoulos GC, Saner F, Kaiser G, Radtke A, Klein CG, Erim Y, de Geest S, Paul A, Gerken G, Cicinnati VR. Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation. Transpl Int 2011 [Ebup ahead of print] Capitole de carte: 17 Articole tip review: 6 Lucrări publicate în rezumat la manifestări stiintifice internationale si nationale:210 Comunicari orale: 19 internationale, 30 nationale, 25 regionale Postere prezentate la manifestări stiintifice internationale si nationale: 223 Publicatii cu caracter educational: 9
In prezent: Cercetator stiintiific grad III, medic primar gastroenterologie Centrul de Gastroenterologie si Hepatologie Institutul Clinic Fundeni
CURRICULUM VITAE Nume: VĂDAN ROXANA Data naşterii: 3.05. 1970 Locul naşterii: Bucureşti Adresa (spital): Centrul de Gastroenterologie si Hepatologie, Institutul Clinic Fundeni; Soseaua Fundeni nr 258,
More informationCURRICULUM VITAE CRISTIAN GHEORGHE
1 CURRICULUM VITAE CRISTIAN GHEORGHE Profesor, medic primar medicină internă si gastroenterologie, doctor în medicină, şef secţia I Gastroenterologie, Centrul pentru Boli Digestive si Transplant Hepatic,
More information4th UpDate on Hepatology
4th UpDate on Hepatology Course Bucharest 2017, Romania 6 th - 7 th April 2017 Bucharest - Crowne Plaza Hotel Hepatology 2017 A panoramic view" Liana GHEORGHE Course Directors Ioan SPOREA Anca TRIFAN 4
More informationDynamics of the Romanian Waiting List for Liver Transplantation after Changing Organ Allocation Policy
Dynamics of the Romanian Waiting List for Liver Transplantation after Changing Organ Allocation Policy Liana Gheorghe 1, Speranta Iacob 1, Razvan Iacob 1, Gabriela Smira 1, Corina Pietrareanu 1, Doina
More informationAccess to Peginterferon plus Ribavirin Therapy for Hepatitis C in Romania between
Access to Peginterferon plus Ribavirin Therapy for Hepatitis C in Romania between 2002-2009 Liana Gheorghe 1, Oliviu Pascu 2, Emanoil Ceausu 3, Irma Eva Csiki 4, Speranta Iacob 1, Florin Caruntu 5, Iulia
More informationLIVER TRANSPLANTATION SURVIVAL IN HEPATOCELLULAR CARCINOMA. FUNDENI CLINICAL INSTITUTE EXPERIENCE
THE PUBLISHING HOUSE OF THE ROMANIAN ACADEMY MEDICINE Research article LIVER TRANSPLANTATION SURVIVAL IN HEPATOCELLULAR CARCINOMA. FUNDENI CLINICAL INSTITUTE EXPERIENCE Gabriela ȘMIRA¹, Vladislav BRASOVEANU²,
More informationLiver Transplantation: The End of the Road in Chronic Hepatitis C Infection
University of Massachusetts Medical School escholarship@umms UMass Center for Clinical and Translational Science Research Retreat 2012 UMass Center for Clinical and Translational Science Research Retreat
More informationCURRICULUM VITAE. Vereanu Anca Delia. Adresa: Str. Erou Iancu Nicolae 67 B, Data nasterii : 31 iulie Nationalitatea : Romana
CURRICULUM VITAE Vereanu Anca Delia Adresa: Str. Erou Iancu Nicolae 67 B, Vila 7, Voluntari, Ilfov Data nasterii : 31 iulie 1967 Nationalitatea : Romana Statut civil: Casatorita Telefon mobil: +40 722
More informationPROGRAMME AT A GLANCE
PROGRAMME AT A GLANCE Hotel Hyatt Andaz Hotel Pullman Date Hall-H1 Hall-H2 Hall-P1 Hall-P2 Hall-P3 Hall-P4 Hall-P5 Hall-P6 Basic science workshop 1 Basic Science Workshop 2 Postgraduate Course - Liver
More informationPRELIMINARY SCIENTIFIC PROGRAM :50 Meet the experts- Molecular mechanisms in IBD from basic science to therapy. Franco-Romanian Meeting
PRELIMINARY SCIENTIFIC PROGRAM RCCC Annual Meeting 27th-29th of SEPEMBER 2018 Thursday 27 th of September 2018 7.30-8.00 Registration 8.00-9:50 Meet the experts- Molecular mechanisms in IBD from basic
More informationLiver transplantation and hepatitis C virus
Liver transplantation and hepatitis C virus Where do we come from? Where are we? Where are we going? François Durand Hépatologie & Réanimation Hépato-Digestive INSERM U1149 Hôpital Beaujon, Clichy HCV:
More informationIS THERE A DIFFERENCE IN LIVER CANCER RATES IN PATIENTS WHO RECEIVE TREATMENT FOR HEPATITIS?
IS THERE A DIFFERENCE IN LIVER CANCER RATES IN PATIENTS WHO RECEIVE TREATMENT FOR HEPATITIS? Dr. Sammy Saab David Geffen School of Medicine, Los Angeles, USA April 2018 DISCLAIMER Please note: The views
More informationTHE ROMANIAN HEPATITIS ACTION PAPER
1 THE ROMANIAN HEPATITIS ACTION PAPER PRODUCED BY: EUROPEAN LIVER PATIENTS ASSOCIATION APAH-RO WRITTEN BY: ACHIM KAUTZ, POLICY DIRECTOR, ELPA CRISTINA ENESCU, REPRESENTATIVE, APAH-RO LILYANA CHAVDAROVA,
More informationNUME: Maria-Magdalena Gurzun
NUME: Maria-Magdalena Gurzun ADRESĂ: Spitalul Universitar de Urgență Militar Central, Strada Plevnei, nr 134, telefon: 021.319.30.56 Fax: 021.312.18. DATE PERSONALE: Locul și data nașterii: 15 iulie, 1982,
More informationSCIENTIFIC PROGRAM. The First Franco-Romanian Meeting
SCIENTIFIC PROGRAM RCCC Annual Meeting 27 th -29 th of September 2018 The First Franco-Romanian Meeting Thursday 27 th of September 2018 7.30-8.15 Registration 8.15-9:45 Meet the experts The therapeutic
More informationLife After SVR for Cirrhotic HCV
Life After SVR for Cirrhotic HCV KIM NEWNHAM MN, NP CIRRHOSIS CARE CLINIC UNIVERSITY OF ALBERTA Objectives To review the benefits of HCV clearance in cirrhotic patients To review some of the emerging data
More informationLearning Objectives. After attending this presentation, participants will be able to:
Learning Objectives After attending this presentation, participants will be able to: Describe HCV in 2015 Describe how to diagnose advanced liver disease and cirrhosis Identify the clinical presentation
More informationP R O G R A M. 08:50 09:10 Present and future of surgery of pancreatic cancer: how far can we go?
P R O G R A M Course Day 1, Friday November 2, 2018 08:30 08:00 Official Opening Welcome Address 08:30 08:35 08:35 08:40 08:40 08:45 08:45 08:50 Jakob Izbicki (Germany), EFISDS President T. Seufferlein
More informationTransplant Hepatology
Transplant Hepatology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified
More information3 Workshop on HCV THERAPY ADVANCES New Antivirals in Clinical Practice
3 Workshop on HCV THERAPY ADVANCES New Antivirals in Clinical Practice Rome, 13 December 2013 Management and monitoring of HCC in the future era of DAA s Prof. Massimo Colombo Chairman Department of Liver,
More informationPOST TRANSPLANT OUTCOMES IN PSC
POST TRANSPLANT OUTCOMES IN PSC Kidist K. Yimam, MD Medical Director, Autoimmune Liver Disease Program Division of Hepatology and Liver Transplantation California Pacific Medical Center (CPMC) PSC Partners
More informationPetrescu Bogdan Mircea
Petrescu Bogdan Mircea Pregătire profesională 2000-2006, Universitatea de Medicină şi Farmacie "Carol Davila" Bucureşti, Facultatea Medicină Generală, Licenta 2006 2013 - Medic specialist psihiatru Funcții
More informationHepatitis C Update on New Treatments
Hepatitis C Update on New Treatments Kevork M. Peltekian, MD, FRCPC 44th Annual Dalhousie Spring Refresher Course - Therapeutics April 5 - April 7, 2018 Halifax Convention Centre Disclosures Conflicts
More informationViral Hepatitis The Preventive Potential of Antiviral Therapy. Thomas Berg
Viral Hepatitis The Preventive Potential of Antiviral Therapy Thomas Berg Therapeutic and preventive strategies in patients with hepatitis virus infection Treatment of acute infection Treatment of chronic
More information6 th UpDate. on Hepatology Course Bucharest Romania 2019 Title: From theory to practice in liver disease
6 th UpDate on Hepatology Course Bucharest Romania 2019 Title: From theory to practice in liver disease COURSE DIRECTORS Liana GHEORGHE Anca TRIFAN Ioan SPOREA 5 th - 6 th April 2019 Bucharest Crowne Plaza
More informationThe Disease Burden of Hepatitis C in Belgium : development of a realistic disease control strategy
280 POSITION PAPER : BELGIAN WORKING GROUP FOR HEPATITIS C The Disease Burden of Hepatitis C in Belgium : development of a realistic disease control strategy P. Stärkel 1, D. Vandijck 2,3, W. Laleman 4,
More informationEvaluating HIV Patient for Liver Transplantation. Marion G. Peters, MD Professor of Medicine University of California San Francisco USA
Evaluating HIV Patient for Liver Transplantation Marion G. Peters, MD Professor of Medicine University of California San Francisco USA Slide 2 ESLD and HIV Liver disease has become a major cause of death
More informationDirect-acting antiviral treatment for hepatitis C in liver transplant candidates and recipients
Editorial Direct-acting antiviral treatment for hepatitis C in liver transplant candidates and recipients Nobuhisa Akamatsu, Junichi Togashi, Kiyoshi Hasegawa, Norihiro Kokudo Artificial Organ and Transplantation
More informationImpatto della clearance virale e rischio di carcinoma epatocellulare
EPATITE CRONICA DA HCV: Impatto della clearance virale e rischio di carcinoma epatocellulare Rodolfo Sacco, M.D., PhD Direttore U.O.C. Gastroenterologia ed Endoscopia Digestiva A.O.U. Ospedali Riuniti"
More informationScreening for HCCwho,
Screening for HCCwho, how and how often? Catherine Stedman Associate Professor of Medicine, University of Otago, Christchurch Gastroenterology Department, Christchurch Hospital HCC Global Epidemiology
More informationThe future of liver transplantation for viral hepatitis
The future of liver transplantation for viral hepatitis François Durand Hepatology & Liver Intensive Care Hospital Beaujon, Clichy University Paris Diderot France Liver transplantation in France 2013:
More informationDAA-based treatment in cirrhotic and post-transplanted patients. Audrey Coilly, MD Hôpital Paul Brousse, Villejuif, France
DAA-based treatment in cirrhotic and post-transplanted patients Audrey Coilly, MD Hôpital Paul Brousse, Villejuif, France Cirrhosis and transplantation 2 populations with similar issues Hepatic impairment
More informationTumor incidence varies significantly, depending on geographical location.
Hepatocellular carcinoma is the 5 th most common malignancy worldwide with male-to-female ratio 5:1 in Asia 2:1 in the United States Tumor incidence varies significantly, depending on geographical location.
More informationManagement of CHC G1 patients who are relapsers or non-responders to Peg IFN and RBV therapy: Wait or Triple Therapy?
Management of CHC G1 patients who are relapsers or non-responders to Peg IFN and RBV therapy: Wait or Triple Therapy? Prof. Teerha Piratvisuth NKC Institute of Gastroenterology and Hepatology Prince of
More informationANDREI-DUMITRU MARGULESCU
Curriculum vitae INFORMAŢII PERSONALE ANDREI-DUMITRU MARGULESCU Str. Maica Domnului 10, 023723 Bucuresti (Romania) 021 3180522 0726335271 andrei_marg@yahoo.com Sexul Masculin Data naşterii 27/06/1979 LOCUL
More informationViral Hepatitis And Liver Transplantation
Viral Hepatitis And Liver Transplantation Dr.Zeki KARASU Ege University Medical School Dep. Gastroenterology Hepatitis B 3-7 10 % HBV infection in liver transplant recipients, in western countries. 120
More informationHepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan;
Editorial The unexpected high risk of occurrence or recurrence of hepatocellular carcinoma after successful antiviral therapy with interferon-free direct-acting antivirals Ming-Lung Yu 1,2,3, Chung-Feng
More information29th Viral Hepatitis Prevention Board Meeting
29th Viral Hepatitis Prevention Board Meeting Madrid, November 2006 Treatment of chronic hepatitis C José M. Sánchez-Tapias Liver Unit Hospital Clínic University of Barcelona Spain CHRONIC HEPATITIS C
More informationUltrasound screening for hepatocellular carcinoma in patients with advanced liver fibrosis. An overview.
Review Med Ultrason 2014, Vol. 16, no. 2, 139-144 DOI: Ultrasound screening for hepatocellular carcinoma in patients with advanced liver fibrosis. An overview. Mirela Dănilă, Ioan Sporea Gastroenterology
More informationCurrent Status of HBV and Liver Transplant
Current Status of HBV and Liver HBV as Indication for Liver ation in U.S. Significant decrease in rate of wait listing for decompensated cirrhosis since 2003 (since s) No change in rate of wait listing
More informationASSESSMENT AND MANAGEMENT OF POTENTIAL LIVER TRANSPLANT CANDIDATES
ASSESSMENT AND MANAGEMENT OF POTENTIAL LIVER TRANSPLANT CANDIDATES James YY Fung MBChB, MD, FRACP, FHKCP, FHKAM Consultant & Hon. Assoc. Professor Liver Transplant Center Department of Surgery, Queen Mary
More informationSCIENTIFIC PROGRAM Pharma Symposium Takeda: Changing the Game in IBD. Speakers: Bogdan Mateescu, Lucian Negreanu
SCIENTIFIC PROGRAM RCCC Annual Meeting 28 th -30 th of SEPEMBER 2017 Thursday 28 th of September 2017 ECCO educational workshop 17.30-18.30 Pharma Symposium Takeda: Changing the Game in IBD. Speakers:
More informationSpitalul Clinic Judetean de Urgenta str Clinicilor 3-5, , Cluj Napoca (Romania)
Europass Curriculum Vitae Informatii personale Nume, Prenume (Nume anterior casatoriei: Padure ) Adresa Str. C.A.Rosetti, Nr. 16, Cluj Napoca (Romania) Telefon 0040745459080 E-mail(s) munteana2@yahoo.com
More informationThe impact of the treatment of HCV in developing Hepatocellular Carcinoma
The impact of the treatment of HCV in developing Hepatocellular Carcinoma Paul Y Kwo, MD Professor of Medicine Medical Director, Liver Transplantation Gastroenterology/Hepatology Division Indiana University
More informationWorldwide Causes of HCC
Approach to HCV Treatment in Patients with HCC JORGE L. HERRERA, MD, MACG UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE Worldwide Causes of HCC 60% 50% 40% 54% 30% 20% 10% 31% 15% 0% Hepatitis B Hepatitis
More informationDr. Cornelia NITIPIR. Curriculum vitae Europass. Informatii personale. Nume/Prenume: Adresa(e):... Telefon(oane):... Data nasterii: 16 iunie 1969
Curriculum vitae Europass Informatii personale Nume/Prenume: Dr. Cornelia NITIPIR Adresa(e):... Telefon(oane):... E-mail(uri): nitipir2003@yahoo.com Nationalitate (tati): Romaneasca Data nasterii: 16 iunie
More informationOutcome and Characteristics of Patients on the Liver Transplant Waiting List: Shiraz Experience
63 Original Article Outcome and Characteristics of Patients on the Liver Transplant Waiting List: Shiraz Experience F Khademolhosseini 1, SA Malekhosseini 2, H Salahi 2, S Nikeghbalian 2, A Bahador 2,
More informationAntiviral agents in HCV
Antiviral agents in HCV : Upcoming Therapeutic Options Su Jong Yu, M.D., Ph.D. Department of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine Estimated 170 Million
More informationHepatitis Alert: Management of Patients With HCV Who Have Achieved SVR
Hepatitis Alert: Management of Patients With HCV Who Have Achieved SVR This program is supported by educational grants from AbbVie, Gilead Sciences, and Merck About These Slides Please feel free to use,
More informationHepatitis C: New Antivirals in the Liver Transplant Setting. Maria Carlota Londoño Liver Unit Hospital Clínic Barcelona
Hepatitis C: New Antivirals in the Liver Transplant Setting Maria Carlota Londoño Liver Unit Hospital Clínic Barcelona Patient survival Hepatitis C and Liver Transplantation Years after transplantation
More informationHepatology For The Nonhepatologist
Hepatology For The Nonhepatologist Andrew Aronsohn, MD Associate Professor of Medicine University of Chicago Chicago, Illinois Learning Objectives After attending this presentation, learners will be able
More informationWhite Nights of Hepatology 2016
White Nights of Hepatology 2016 Saint Petersburg, 3 June 2016 Long-term treatment of Chronic hepatitis B - a key to HCC prevention Massimo Colombo Chairman Department of Liver, Kidney, Lung and Bone Marrow
More informationSurveillance for Hepatocellular Carcinoma
Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April
More informationCost effectiveness of sofosbuvir and ledipasvir (Harvoni ) in combination with other medicinal products for the treatment of hepatitis C infection
Cost effectiveness of sofosbuvir and ledipasvir (Harvoni ) in combination with other medicinal products for the treatment of hepatitis C infection The NCPE has issued a recommendation regarding the cost
More informationa series of fact sheets written by experts in the field of liver disease HCV DISEASE PROGRESSION
www.hcvadvocate.org HCSP FACT SHEET Foreword Over years or decades, chronic hepatitis C virus (HCV) infection can progress to severe liver problems including cirrhosis and hepatocellular carcinoma (HCC).
More informationThe 10th National Symposium on Inflammatory Bowel Diseases
1958 The 10 th National Symposium on Inflammatory Bowel Diseases Crowne Plaza Hotel, Bucharest, 27 th - 29 th of September 2018 The First Franco- Romanian Meeting Program www.rccc-congress.ro office.rccc@gmail.com
More informationPEDIATRIC LIVER TRANSPLANTATION: INDICATIONS AND TECHNICAL PROCEDURES
Annals of Academy of Romanian Scientists Online edition Series: Medical Sciences ISSN 2285-4150 Volume 1, Number 1/2010 41 PEDIATRIC LIVER TRANSPLANTATION: INDICATIONS AND TECHNICAL PROCEDURES Irinel POPESCU
More informationBasic patterns of liver damage what information can a liver biopsy provide and what clinical information does the pathologist need?
Basic patterns of liver damage what information can a liver biopsy provide and what clinical information does the pathologist need? Rob Goldin r.goldin@imperial.ac.uk @robdgol FATTY LIVER DISEASE Brunt
More informationAccepted Manuscript. Unexpected high incidence of hepatocellular carcinoma in patients with hepatitis C in the era of DAAs: too alarming?
Accepted Manuscript Unexpected high incidence of hepatocellular carcinoma in patients with hepatitis C in the era of DAAs: too alarming? Qing-Lei Zeng, Zhi-Qin Li, Hong-Xia Liang, Guang-Hua Xu, Chun-Xia
More informationLiver disease in 2017: challenges and opportunities
Liver disease in 2017: challenges and opportunities Dr Matthew Cowan Consultant Gastroenterologist and Hepatologist Surrey and Sussex Healthcare NHS Trust Faculty of Physician Associates 2 nd National
More informationHepatocellular Carcinoma: Can We Slow the Rising Incidence?
Hepatocellular Carcinoma: Can We Slow the Rising Incidence? K.Rajender Reddy M.D. Professor of Medicine Director of Hepatology Medical Director of Liver Transplantation University of Pennsylvania Outline
More informationHCV care after cure. This program is supported by educational grants from
HCV care after cure This program is supported by educational grants from Raffaele Bruno,MD Department of Infectious Diseases, Hepatology Outpatients Unit University of Pavia Fondazione IRCCS Policlinico
More informationLiver transplantation for HCV and HBV in The Czech Republic. Soňa Fraňková Institute for Clinical and Experimental Medicine Prague, Czech Republic
Liver transplantation for HCV and HBV in The Czech Republic Soňa Fraňková Institute for Clinical and Experimental Medicine Prague, Czech Republic Disclosures Speaking fees: Abbvie, Gilead, MSD, Novartis
More informationNational Horizon Scanning Centre. Enhanced Liver Fibrosis Test (ELF) for evaluating liver fibrosis. June 2008
Enhanced Liver Fibrosis Test (ELF) for evaluating liver fibrosis June 2008 This technology summary is based on information available at the time of research and a limited literature search. It is not intended
More informationAbstract and Introduction. Patients and Methods. M. Hedenstierna; A. Nangarhari; A. El-Sabini; O. Weiland; S.
www.medscape.com Cirrhosis, High Age and High Body Mass Index Are Risk Factors for Persisting Advanced Fibrosis After Sustained Virological Response in Chronic Hepatitis C M. Hedenstierna; A. Nangarhari;
More information9th Paris Hepatitis Conference
9th Paris Hepatitis Conference Paris, 12 January 2016 Treatment of hepatocellular carcinoma: beyond international guidelines Massimo Colombo Chairman Department of Liver, Kidney, Lung and Bone Marrow Units
More informationTransient elastography in chronic viral liver diseases
4 th AISF POST-MEETING COURSE Roma, 26 Febbraio 2011 Transient elastography in chronic viral liver diseases CRISTINA RIGAMONTI, M.D., Ph.D. Transient elastography (TE): a rapid, non-invasive technique
More informationLiver Pathology and the Clinician in 2015: At the Crossroads. Thomas D. Schiano, M.D. Mount Sinai Medical Center New York, New York
Liver Pathology and the Clinician in 2015: At the Crossroads Thomas D. Schiano, M.D. Mount Sinai Medical Center New York, New York DISCLOSURES Consultant for: Salix Merck Gilead BMS Synageva Research funding:
More informationPrognostic Significance of CD44 Expression in Hepatocellular Carcinoma Following a Potentially Curative Treatment
ORIGINAL PAPER J. Transl. Med. Res 2016;21(4):267-273 DOI: 10.21614/jtmr-21-4-101 Prognostic Significance of CD44 Expression in Hepatocellular Carcinoma Following a Potentially Curative Treatment Razvan
More informationWorldwide Causes of HCC
Approach to HCV Treatment in Patients with HCC Mark W. Russo, MD, MPH, FACG Carolinas HealthCare System Charlotte Worldwide Causes of HCC 60% 50% 40% 30% 20% 10% 0% 54% 31% 15% Hepatitis B Hepatitis C
More informationCornerstones of Hepatitis B: Past, Present and Future
Cornerstones of Hepatitis B: Past, Present and Future Professor Man-Fung Yuen Queen Mary Hospital The University of Hong Kong Hong Kong 1 Outline Past Natural history studies Development of HBV-related
More informationNume / Prenume Negreanu Lucian Conferentiar Universitar Medician Interna si Gastroenterologie, Abilitat
Curriculum vitae Europass Informaţii personale Nume / Prenume Negreanu Lucian Conferentiar Universitar Medician Interna si Gastroenterologie, Abilitat Adresă(e) Spitalul UnivBucuresti, splaiul independentei
More informationTreatment of Hepatitis C Recurrence after Liver Transplantation. Maria Carlota Londoño Liver Unit Hospital Clínic Barcelona
Treatment of Hepatitis C Recurrence after Liver Transplantation Maria Carlota Londoño Liver Unit Hospital Clínic Barcelona Agenda 1. Introduction 2. Treatment options for hepatitis C recurrence after transplantation
More informationTreatment of genotype 4 patient. with cirrhosis. Vincent LEROY Clinique Universitaire d Hépato-Gastroentérologie INSERM U823 CHU de Grenoble
Treatment of genotype 4 patient with cirrhosis Vincent LEROY Clinique Universitaire d Hépato-Gastroentérologie INSERM U823 CHU de Grenoble Clinical case 52 year-old patient Intra-venous drug user 1987-1989
More informationDoina-Andrada MIHAI CURRICULUM VITAE. Informaţii personale Data şi locul naşterii Nume purtat anterior căsătoriei Adresă , Bucureşti Bojin
CURRICULUM VITAE Doina-Andrada MIHAI Informaţii personale Data şi locul naşterii Nume purtat anterior căsătoriei Adresă E-mail 09.05.1974, Bucureşti Bojin Institutul Național de Diabet, Nutriţie şi Boli
More informationLong-term Clinical Outcomes and Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with HBsAg Seroclearance
Long-term Clinical Outcomes and Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with HBsAg Seroclearance Gi-Ae Kim, Han Chu Lee *, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim,
More informationHepatitis C Management and Treatment
Hepatitis C Management and Treatment Kaya Süer Near East University Faculty of Medicine Infectious Diseases and Clinical Microbiology 1 Discovery of Hepatitis C Key facts Hepatitis C: the virus can cause
More informationThe role of ARFI and APRI in diagnosis of liver fibrosis on patients with common chronic liver diseases
RESEARCH ARTICLE The role of ARFI and APRI in diagnosis of liver fibrosis on patients with common chronic liver diseases Objective: This study aimed to investigate the value of liver fibrosis assessment
More informationCancer Mortality in Romania, Digestive Sites: Esophagus, Stomach, Colon and Rectum, Pancreas, Liver, Gallbladder and Biliary Tree
ORIGINAL PAPER Cancer Mortality in Romania, 1955-2004. Digestive Sites: Esophagus, Stomach, Colon and Rectum, Pancreas, Liver, Gallbladder and Biliary Tree Simona Vălean 1, Petru Armean 2, Simona Resteman
More informationHCC: Is it an oncological disease? - No
June 13-15, 2013 Berlin, Germany Prof. Oren Shibolet Head of the Liver Unit, Department of Gastroenterology Tel-Aviv Sourasky Medical Center and Tel-Aviv University HCC: Is it an oncological disease? -
More informationHepatitis C Medications Hawaii PRIOR AUTHORIZATION REQUEST FORM
Please complete this entire form and fax it to: 866-940-7328. If you have questions, please call 800-310-6826. This form contains multiple pages. Please complete all pages to avoid a delay in our decision.
More informationRELEVANCE OF TRANSIENT ELASTOGRAPHY (FIBROSCAN ) IN EVALUATION OF HEPATIC B VIRUS CHRONICALLY INFECTED PATIENTS
ORIGINAL ARTICLES RELEVANCE OF TRANSIENT ELASTOGRAPHY (FIBROSCAN ) IN EVALUATION OF HEPATIC B VIRUS CHRONICALLY INFECTED PATIENTS Diana Nicolita, Ioan Sporea, Roxana Sirli, Alexandra Deleanu, Adriana Tudora,
More informationPrior Authorization Guideline
Prior Authorization Guideline Guideline Name Sovaldi (sofosbuvir) Formulary UnitedHealthcare Community & State Formulary Note Approval Date 2/19/2014 Revision Date 7/8/2014 1. Indications Drug Name: Sovaldi
More informationTHE EFFICACY OF THE PEGINTERFERON TREATMENT IN CHRONIC HEPATITIS HDV AND COMPENSATE LIVER CIRRHOSIS
Rev. Med. Chir. Soc. Med. Nat., Iaşi 2014 vol. 118, no. 2 INTERNAL MEDICINE - PEDIATRICS ORIGINAL PAPERS THE EFFICACY OF THE PEGINTERFERON TREATMENT IN CHRONIC HEPATITIS HDV AND COMPENSATE LIVER CIRRHOSIS
More informationHEPATITIS WEB STUDY. Treatment of Hepatitis C following Liver Transplantation
HEPATITIS WEB STUDY Treatment of Hepatitis C following Liver Transplantation Terry D. Box, MD Associate Professor of Medicine Division of Gastroenterology/Hepatology University of Utah Health Sciences
More informationApproved regimens for cirrhotic patients
5th Workshop on HCV THERAPY ADVANCES New antivirals in clinical practice Approved regimens for cirrhotic patients Amsterdam, 4-5 december 2015 Disease burden in Spain 400000 350000 300000 F0 Peak cirrhosis
More informationBarnes, Maisha. Habib, Adil. Kedia, Prashant
Study Title PI Area of Discipline A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 12-Month, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-
More informationManagement of autoimmune hepatitis. Pierre-Emmanuel RAUTOU Inserm U970, Paris Service d hépatologie, Hôpital Beaujon, Clichy, France
Management of autoimmune hepatitis Pierre-Emmanuel RAUTOU Inserm U970, PARCC@HEGP, Paris Service d hépatologie, Hôpital Beaujon, Clichy, France 41 year-old woman, coming to emergency department for fatigue
More informationANTIVIRAL THERAPY FOR HCV. Alfredo Alberti
CLINICAL IMPACT OF SVR AFTER ANTIVIRAL THERAPY FOR HCV Alfredo Alberti Department of Histology,Microbiology and Medical Biotechnologies Molecular Hepatology Unit Venetian Institute of Molecular Medicine
More informationNew HCV reimbursement criteria Chronic hepatitis C regardless of fibrosis stage if:
New HCV reimbursement criteria 01-2018 Chronic hepatitis C with F2 fibrosis stage Chronic hepatitis C regardless of fibrosis stage if: HIV-HCV coinfection HBV-HCV coinfection Listed for or post-solid organ
More informationMedInform. HBV DNA loss in Bulgarian patients on NUC therapy. Speed related factors. (NUC related speed of HBV DNA loss in Bulgaria) Original Article
DOI: 10.18044/Medinform.201852.897 ISSUE 3, 2018 HBV DNA loss in Bulgarian patients on NUC therapy. Speed related factors. (NUC related speed of HBV DNA loss in Bulgaria) Donika Krasteva, Radosveta Tomova,
More informationNew HCV reimbursement criteria Chronic hepatitis C regardless of fibrosis stage if:
New HCV reimbursement criteria 01-2018 Chronic hepatitis C with F2 fibrosis stage Chronic hepatitis C regardless of fibrosis stage if: HIV-HCV coinfection HBV-HCV coinfection Listed for or post-solid organ
More informationSafety of Treatment in Cirrhotics in the Era of New Antiviral Therapies for Hepatitis C Virus
Safety of Treatment in Cirrhotics in the Era of New Antiviral Therapies for Hepatitis C Virus JEFFREY NADELSON MD, ALAN EPSTEIN MD, THOMAS SEPE MD BOSTON UNIVERSITY SCHOOL OF MEDICINE ROGER WILLIAMS MEDICAL
More informationAccepted Manuscript. Letter to the Editor. Reply to: From the CUPIC study: Great times are not coming (?)
Accepted Manuscript Letter to the Editor Reply to: From the CUPIC study: Great times are not coming (?) Christophe Hezode, Helene Fontaine, Yoann Barthe, Fabrice Carrat, Jean-Pierre Bronowicki PII: S0-()00-
More informationةي : لآا ةرقبلا ةروس
سورة البقرة: اآلية HCV RELAPSERS AND NONRESPONDERS: How to deal with them? BY Prof. Mohamed Sharaf-Eldin Prof. of Hepatology and Gastroenterology Tanta University Achieving SVR The ability to achieve a
More informationRESULTS OF PEGINTERFERON ALFA-2A TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B IN THE WESTERN PART OF ROMANIA
ORIGINAL ARTICLE RESULTS OF PEGINTERFERON ALFA-2A TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B IN THE WESTERN PART OF ROMANIA Roxana Șirli 1 *, Ioan Sporea 1, Milana Szilaski 1, Manuela Curescu 2, Mirela
More informationEsophageal Varices Beta-Blockers or Band Ligation. Cesar Yaghi MD Hotel-Dieu de France University Hospital Universite Saint Joseph
Esophageal Varices Beta-Blockers or Band Ligation Cesar Yaghi MD Hotel-Dieu de France University Hospital Universite Saint Joseph Esophageal Varices Beta-Blockers or Band Ligation? Risk of esophageal variceal
More informationRJGE VOL.12, NR.2, JUNE 2003
RJGE VOL.12, NR.2, JUNE 2003 ORIGINAL PAPER Correlation of sicam-1 and svcam-1 Level with Biochemical, Histological and Viral Findings in Chronic Hepatitis C after Interferon-a+ Ribavirin Therapy Corina
More informationBasic patterns of liver damage what information can a liver biopsy provide and what clinical information does the pathologist need?
Basic patterns of liver damage what information can a liver biopsy provide and what clinical information does the pathologist need? Rob Goldin r.goldin@imperial.ac.uk Fatty liver disease Is there fatty
More information